|
Diabetes Medication Article
FDA's Role in Regulating Insulin
FDA's Center for Drug Evaluation and Research (CDER) oversees drug products, including insulin. CDER makes sure that drugs sold in the U.S. are safe and effective. The center evaluates new types of insulin products, and it regulates the manufacturing, labeling, and advertising of insulin products.
Companies wanting to market insulin products are responsible for testing their products and submitting data showing they are safe and effective. At CDER, teams of doctors, statisticians, and scientists review new drug applications (NDAs). In some cases, FDA seeks help from advisory committees made up of outside experts.
Once a new insulin product is on the market, CDER monitors its quality and makes sure that its manufacturer follows FDA laws and regulations. CDER also monitors insulin products carefully after they are approved to identify any unexpected side effects. Through a system called MedWatch, health professionals and consumers can report serious adverse reactions to any medical product. CDER collects information from MedWatch and the drug industry and conducts statistical evaluations on drug usage, adverse reactions, poisonings, safety, and effectiveness. If necessary, CDER shares information with patients and health professionals.
Diabetes Testing Center
Heart News Center
Hot Home Gym Reviews
The Secret Wisdom You Have Inside
Get Rid of Your Belly fat
Med Insulin Pump News
Med Insulin Pump
IMPORTANT: Bing News RSS feed has moved!
D Medical Industries Ltd. (Nasdaq: DMED); TASE:DMED) has signed its fourth distribution agreement in the US for its insulin pump. Subsidiary Spring Health Solutions Inc. signed a non-exclusive agreement with Better Living Now Inc. for distribution of its ...
Read moreD Medical signs 4th US insulin pump deal
TIRAT CARMEL, Israel, Jan. 11, 2012 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (Nasdaq:DMED) (TASE:DMED) ("D. Medical" or "Company"), a medical device company engaged through its subsidiaries in the research, development, manufacture and ...
Read moreD. Medical Receives CE Mark Approval for "Spring Zone" Durable Insulin Pump
D. Medical has developed durable and semi-disposable insulin pumps, which continuously infuse insulin into a patient's body, using its proprietary spring-based delivery technology. D. Medical believes that its spring-based delivery mechanism is ...
Read moreExpansion of D. Medical's U.S. Distribution Network for Spring Universal Infusion Sets Continues
Blood tests, insulin pumps and the many kinds of human and animal insulin now available make it easier to control how much is required by an individual diabetic. Karen Addington, chief executive of medical research charity, JDRF, says it is still a fine balance.
Read more'I was treated by the pioneers of insulin in 1930'
The pump is now eligible for government-funded medical insurance reimbursements, and for recommendation by doctors and hospitals. Diabetics have several choices when it comes to administering insulin. In the past, the default choice was to inject insulin ...
Read moreIsraeli Made Insulin Pump Wows EU
A medical breakthrough Exactly 90 years ago today a 14-year ... Since then, I’ve seen a lot of changes in the way people use insulin and these days I use an insulin pump to control my own condition. I’m thrilled to see that people with ...
Read moreInsulin 90 years on – but rate of diabetes still soaring
Hoffmann-La Roche Ltd., Animas Corporation, Hindustan Syringes & Medical Devices Ltd. and Abbott Laboratories ... understand and capitalize. 4.5.1 Traditional Insulin Pump Accessories, Brazil , Overall Revenue (2003-2017) 55 4.5.2 Traditional ...
Read moreInsulin Delivery Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
This time it's the unit that makes insulin pumps for diabetics, Animas Corp., that's being investigated. The Food and Drug Administration has warned Animas that unless it corrects violations soon, it could face fines and other sanctions for selling faulty ...
Read moreFDA: J&J delayed reporting insulin pump problems
Arnot Health will host an Insulin Pump Support Group meeting on Jan. 19 at 7:30 p.m. at the Arnot Health Horseheads Medical Office Building, 100 John Roemmelt Drive. The meeting will feature a presentation by Ellen Smagner, director of the Arnot Health ...
Read more